Reduced expression of neurofibromin in human meningiomas
1997

Reduced Expression of Neurofibromin in Human Meningiomas

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): V Sundaram, JH Lee, JA Harwalkar, DJ Stein, M Roudebush, DW Stacey, M Golubic

Primary Institution: Cleveland Clinic Foundation

Hypothesis

The loss of function of neurofibromin is involved in meningioma development.

Conclusion

Reduced expression and GTPase activity of neurofibromin were found in about 28% of the meningiomas analyzed.

Supporting Evidence

  • Neurofibromin was detected in most meningiomas, but its levels were significantly reduced in some.
  • Reduced neurofibromin expression was associated with diminished GTPase activity.
  • About 28% of the meningiomas analyzed showed reduced neurofibromin levels.

Takeaway

This study found that a protein called neurofibromin is less active in some brain tumors called meningiomas, which might help those tumors grow.

Methodology

The study analyzed neurofibromin expression in human leptomeningeal cells and 18 meningioma samples using immunoblotting and immunoprecipitation.

Limitations

The study did not explore the role of other potential GAP proteins in meningiomas.

Participant Demographics

Included 17 sporadic meningiomas and 1 NF2-related meningioma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication